HydroCision names Tranchemontagne as CEO | Personnel Moves – March 12, 2019

HydroCision said early this month that it tapped former Smith & Nephew (NYSE:SNN) exec Alain Tranchemontagne as its new chief executive officer. Prior to joining Boston-based HydroCision, Tranchemontagne held a position as U.S. business commercial development senior VP at Smith & Nephew. Before joining Smith & Nephew, Tranchemontagne also held positions at Covidien in senior marketing roles in the patient care division. “We are delighted to have Alain spearhead the next growth chapter in HydroCision’s future. The board was impressed with Alain’s proven track record at major medical device companies, his leadership and market development experience, as well as his passion and energy to broaden the use of our patented, proprietary technology,” board chair John Schulte said in a press release. “I’m incredibly honored to be joining HydroCision, and I look forward to working closely with the dedicated HydroCision employees and the Board to deliver on the enormous opportunity that lies ahead. I’m also eager to quickly accelerate HydroCision’s growth trajectory, particularly leveraging our unique and differentiated technology into new surgical applications,” Tranchemontagne said in a prepared statement.  Senseonics taps Kaufman as chief medical officer Senseonics (NYSE:SENS) said this month it named Dr. Francine Kaufman as its new chief medical officer, effective immediately. Kaufman previously served as a direct...
Source: Mass Device - Category: Medical Devices Authors: Tags: Business/Financial News Aethlon Medical Inc. camberspine Humacyte HydroCision Inc. Invictus Medical IRRAS johnsonandjohnson MediWounds qureai Senseonics Smith & Nephew SynCardia V-Wave Virta Health Source Type: news